Evidence map›Paper›PMID 37859438›Full record

ReviewClinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology2023

Peripheral Markers of Suicidal Behavior: Current Findings and Clinical Implications.

Hee-Ju Kang, Ju-Wan Kim, Sung-Wan Kim, Jung-Soo Han, In Kyoon Lyoo, Jae-Min Kim

Open access · diamondAbstract readReview
In one paragraph

Review in Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.7field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 7 citations in OpenAlex.

  1. Low 5HTJournal of neurochemistry · 2026
    Review
  2. Article
  3. Article
  4. Interplay between Stressful Life Events and Interleukin-1β on 12-week Antidepressant Response in Depressive Patients.Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Observational
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Hee-Ju KangDepartments of Psychiatry, Chonnam National University Medical School, Gwangju, Korea.ORCID https://orcid.org/0000-0002-4784-4820
Ju-Wan KimDepartments of Psychiatry, Chonnam National University Medical School, Gwangju, Korea.ORCID https://orcid.org/0000-0002-9888-1090
Sung-Wan KimDepartments of Psychiatry, Chonnam National University Medical School, Gwangju, Korea.ORCID https://orcid.org/0000-0002-6739-2163
Jung-Soo HanDepartment of Biological Science, Konkuk University, Seoul, Korea.ORCID https://orcid.org/0000-0001-8447-4518
In Kyoon LyooEwha Brain Institute, Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul, Korea.ORCID https://orcid.org/0000-0002-9717-1935
Jae-Min KimDepartments of Psychiatry, Chonnam National University Medical School, Gwangju, Korea.ORCID https://orcid.org/0000-0001-7409-6306
Chonnam National University · KREwha Womans University · KRKonkuk University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Biomarkers of suicidal behavior (SB), particularly peripheral biomarkers, may aid in the development of preventive and intervention strategies. The peripheral biomarkers of SB should be easily accessible, cost-effective, and minimally invasive. To identify peripheral biomarkers of SB, we summarized the current knowledge related to SB biomarkers with a focus on suicidal outcomes (suicidal ideation [SI], suicide risk [SR], suicide attempt [SA], and suicide death [SD]), measured site (center or periphery), and study design (cross-sectional or longitudinal). We also evaluated the central findings to validate the findings of peripheral biomarkers of SB. We found reduced peripheral interleukin (IL)-2 levels in individuals with a recent SA, higher cerebrospinal fluid (CSF) IL-6 levels in patients with a current SR and future SD, higher CSF tumor necrosis factor-α levels for current and future SRs, higher high-sensitivity C-reactive protein levels and lower peripheral total cholesterol levels for recent SAs, lower peripheral 5-HT levels for present SR, and a lower folate level for future SR and SA within 1 year. Previous studies have shown inconsistent associations of low peripheral leptin levels with SR and recent SA; therefore, further study is required. Given the multiple determinants of SB and weak associations with single biological markers, combinations of potential biological markers rather than single markers may improve the screening, diagnosis, and prediction of SB.

Indexed as

BiomarkersCross-sectional studiesLongitudinal studiesSuicide

Identifiers

PMID37859438
PMCPMC10591170
OpenAlexW4377861248

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.